• Clearmind Medicine will attend the Frontiers of Mental Health and Recovery Summit in Washington, D.C., the week of Nov. 10, 2026.
• Chief of Global Impact Mary-Elizabeth Gifford will discuss CMND-100 for alcohol use disorder, including Phase II trial updates.
• The two-day summit, convened by BrainFutures, will focus on preparing healthcare systems for psychedelic therapies.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Clearmind Medicine Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202611100732PRIMZONEFULLFEED9874295) on November 10, 2026, and is solely responsible for the information contained therein.